CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ProPhase Labs Inc Company Snapshot
ProPhase Labs Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ProPhase Labs Inc with three other companies in this sector in UNITED STATES : Pulmatrix Inc (2020 sales of $12.63 million ), Rapid Micro Biosystems Inc ($16.08 million of which 68% was Product & service revenue - recurring), and Zogenix Incorporation ($13.64 million of which 100% was Pharmaceutical produc).

Sales Analysis. Sales were up sharply during the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at ProPhase Labs Inc totalled $9.14 million. This is an increase of 152.3% from the $3.62 million in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled $24.41 million, which is 343.0% higher than through the first two quarters of 2020. Sales at ProPhase Labs Inc appear to have some seasonality: during each of the previous 9 years, sales have been highest during the fourth quarter, which has accounted for between 31.2% and 42.1% of the annual sales. ProPhase Labs Inc reported sales of $14.51 million for the year ending December of 2020. This represents an increase of 47.0% versus 2019, when the company's sales were $9.88 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ProPhase Labs Inc
  Stock Performance Chart for ProPhase Labs Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 5.86
(Figures in U.S. Dollars)
1 Week 2.8%   13 Weeks 15.4%  
4 Weeks -21.4%   52 Weeks -34.4%  
 
ProPhase Labs Inc Key Data:
  Ticker: PRPH Country: United States
  Exchanges: NAS BLN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 14,514,000
(Year Ending Jan 2021).
Employees: 95
  Currency: U.S. Dollars Market Cap: 88,803,923
  Fiscal Yr Ends: December Shares Outstanding: 15,154,253
  Share Type: Common Closely Held Shares: 2,711,037
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.